CYTOKINES FROM ACTIVATED T-CELLS INDUCE NORMAL ENDOTHELIAL-CELLS TO ACQUIRE THE PHENOTYPIC AND FUNCTIONAL FEATURES OF AIDS-KAPOSIS SARCOMA SPINDLE CELLS

被引:143
作者
FIORELLI, V
GENDELMAN, R
SAMANIEGO, F
MARKHAM, PD
ENSOLI, B
机构
[1] NCI,TUMOR CELL BIOL LAB,BETHESDA,MD 20892
[2] ADV BIOSCI LABS INC,KENSINGTON,MD 20895
关键词
FVIII-RA; HIV-1; TAT PROTEIN; BFGF; ENDOTHELIAL CELL CYCLE; INFLAMMATORY CYTOKINES; AIDS;
D O I
10.1172/JCI117849
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Kaposi's sarcoma (KS) is a proliferative disease of vascular origin particularly frequent in HIV-1-infected homosexual men (AIDS-KS) and characterized by proliferating spindle-shaped cells, angiogenesis, and inflammatory cell infiltration, Previous work has suggested that KS spindle cells are of endothelial cell origin and that chronic immune activation via the release of inflammatory cytokines may cooperate with basic fibroblast growth factor (bFGF) and the HIV-1 Tat protein in the induction and progression of AIDS-KS. Here we show that KS spindle cells have features of activated endothelial cells, and that conditioned media from activated T cells, rich in the same inflammatory cytokines increased in HIV-1-infected individuals, induce normal endothelial cells to acquire the phenotypic and functional features of KS cells, These include (a) acquisition of a similar pattern of cell surface antigen expression; (b) similar proliferative response to bFGF; (c) induction of the responsiveness to the mitogenic effect of extracellular HIV-1 Tat protein that is now able to promote the G1-S transition of endothelial cell cycle; and (d) induction in nude mice of vascular lesions closely resembling early KS as well as the lesions induced by inoculation of KS cells, These results suggest that chronic immune activation, via release of inflammatory cytokines, may play a role in the induction of KS.
引用
收藏
页码:1723 / 1734
页数:12
相关论文
共 80 条
  • [61] Modlin R.L., Hofman F.M., Kempf R.A., Taylor C.R., Conant M.A., Rea T.H., Kaposi's sarcoma in homosexual men: An immunohistochemical study, J. Am. Acad. Dermatol., 8, pp. 620-627, (1983)
  • [62] Tannenbaum S.H., Gralnick H.R., Gamma-interferon modulates von Willebrand Factor release by cultured human endothelial cells, Blood, 75, pp. 2177-2184, (1990)
  • [63] Van Der Poll T., Van Deventer J.H., Pasterkamp G., Van Mourik J.A., Buller H.R., Cate J.W., Tumor necrosis factor induces von Willebrand Factor release in healthy humans, Thromb. Haemostat., 67, pp. 623-626, (1992)
  • [64] Janier M., Flageul B., Drouet L., Scrobohaci M., Villette M., Palangie A., Cottenot F., Cutaneous and plasma values of von Willebrand factor in AIDS: A marker of endothelial stimulation?, J. Invest. Dermatol., 90, pp. 703-707, (1988)
  • [65] Darzynkiewicz Z., Molecular interactions and cellular change during the cell cycle, Pharmacol. Ther., 21, pp. 143-188, (1983)
  • [66] Kaczmarek L., Kaminska B., Molecular biology of cell activation, Exp. Cell Res., 183, pp. 24-35, (1989)
  • [67] Pardee A.B., G1 events and regulation of cell proliferation, Science (Wash. DC), 246, pp. 603-608, (1989)
  • [68] Zetterberg A., Control of mammalian cell proliferation, Curr. Opin. Cell Biol., 2, pp. 296-300, (1990)
  • [69] Zetterberg A., Larsson O., Coordination between cell growth and cell cycle transit in animal cells, Cold Spring Harbor Symposia on Quantitative Biology, pp. 137-147, (1991)
  • [70] Bybee A., Thomas N.S., Cell cycle regulation, Blood Rev., 5, pp. 117-192, (1991)